ENG and infection: In addition, our increased understanding of disease mechanisms, including data from these mouse models, suggest that anti-inflammatory agents such as anti-TNFα therapy may be beneficial, at least for HHT1 patients, by reducing Eng protein shedding and protecting the vasculature during infections.